StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA)

Investment analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report issued on Tuesday. The brokerage set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Trading Up 1.1 %

RKDA stock opened at $4.81 on Tuesday. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31. The company has a fifty day simple moving average of $5.49 and a 200 day simple moving average of $3.92. The firm has a market cap of $6.54 million, a PE ratio of -1.12 and a beta of 0.88.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Arcadia Biosciences stock. Geode Capital Management LLC bought a new stake in Arcadia Biosciences, Inc. (NASDAQ:RKDA) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences as of its most recent SEC filing. 17.73% of the stock is currently owned by hedge funds and other institutional investors.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.